Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma

Anticancer Res. 2019 Jun;39(6):2757-2765. doi: 10.21873/anticanres.13402.

Abstract

Background/aim: Clear cell renal cell carcinoma (ccRCC) shows variable chromosomal abnormalities. The aim of this study was to assess the prognostic role of ccRCC chromosomal abnormalities in a single-center cohort with an extended follow-up.

Materials and methods: A systematic cytogenetic analysis was performed in 283 consecutive surgically-treated patients for renal masses between 1997 and 2002. Kaplan-Meier and multivariable Cox regression (MCR) models were used to calculate cancer specific survival (CSS).

Results: Among 174 ccRCC patients, the most common abnormality was deletion in chromosome 3 (54.6%). At a median follow-up of 119 months, 38 patients (21.8%) died from RCC. At MCR models, worse CSS was independently predicted by deletions in chromosomes 2, 19, 20 or 22 and insertions in chromosome 18.

Conclusion: Specific ccRCC chromosomal abnormalities are independently associated with worse CSS. Cytogenetic evaluation may direct further genetic analysis for personalized prognostic stratification.

Keywords: Renal cell carcinoma; chromosome imbalance; clear cell; karyotype; prognosis; survival.

MeSH terms

  • Aged
  • Carcinoma, Renal Cell / genetics
  • Carcinoma, Renal Cell / mortality*
  • Carcinoma, Renal Cell / surgery*
  • Chromosome Aberrations*
  • Chromosome Deletion
  • Chromosomes, Human / genetics*
  • Cytogenetics
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Kidney Neoplasms / genetics
  • Kidney Neoplasms / mortality*
  • Kidney Neoplasms / surgery*
  • Male
  • Middle Aged
  • Mutagenesis, Insertional
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies
  • Treatment Outcome